Company intelligence / Profile preview

Optibac Probiotics

Andover, England, United Kingdom

Ownership: Private
Employees: ~132
Development stage: Other

Overview

Optibac Probiotics commercializes a wide range of probiotic supplements containing some of the most researched probiotic strains, most of which are supported by gold-standard clinical trial data for digestive, immune, and women's health. Clinical results support effectiveness for specific indications including reduction of antibiotic-associated diarrhea, maintenance of vaginal flora, and easing of digestive symptoms[1][2][6].

Therapeutic areas: Women's HealthGastroenterologyImmunologyPsychiatry
Modalities: Live biotherapeutic product therapyMicrobial therapyProbiotic
Industry: Food & Nutrition

Partnerships

Independent pharmacies and health food stores (Medipharma Ltd - wholesale)Leading academic and clinical microbiology institutes

Beyond the preview

Go deeper on Optibac Probiotics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Optibac Probiotics.

Explore the full profile